SCHEMBL7345911

SCHEMBL7345911

COc1cc(C)cc2[nH]cnc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.44
▸ ACHE P22303 2/20 0.42
▸ MMP12 P39900 1/20 0.40
▸ PARP1 P09874 1/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ RAD52 P43351 1/20 0.38
▸ RIN1 Q13671 1/20 0.38
▸ CTSS P25774 1/20 0.38
▸ CTSK P43235 1/20 0.38
▸ RET P07949 1/20 0.36
▸ PNP P00491 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ PRNP P04156 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ QPCT Q16769 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29745481 0.80 BRD4 (0.43) BRD4MMP12MEN1KMT2AABL1
SCHEMBL22685864 0.80 BRD4 (0.43) BRD4MMP12MEN1KMT2AABL1
SCHEMBL25413219 0.80 BRD4 (0.43) BRD4MMP12MEN1KMT2AABL1
SCHEMBL29387833 0.80 CTSS (0.45) BRD4MMP12ABL1RAD52RIN1
SCHEMBL13160153 0.78 BRD4 (0.48) BRD4MMP12MEN1KMT2AABL1
SCHEMBL3859120 0.76 PARP1 (0.56) BRD4PARP1MEN1KMT2APNP
SCHEMBL15859686 0.76 PARP1 (0.66) PARP1ABL1RAD52RIN1RET
SCHEMBL30159103 0.75 CA12 (0.50) BRD4KMT2AMAPTHTTQPCT
SCHEMBL28950767 0.74 KDM4E (0.44) BRD4KMT2AALDH1A1MAPTQPCT
SCHEMBL29209466 0.74 TSHR (0.45) BRD4PARP1ALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 — — US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 — — EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 — — US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 — — EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 — — WO disclosed
Send feedback